Literature DB >> 6215060

Interactions between the mitochondrial adenosinetriphosphatase and periodate-oxidized adenosine 5'-triphosphate, an affinity label for adenosine 5'-triphosphate binding sites.

P N Lowe, R B Beechey.   

Abstract

Periodate-oxidized ATP (o-ATP) was prepared as an affinity label of nucleotide binding sites on the chloroform-released ox heart mitochondrial ATPase. In the presence of MgSO4, o-ATP is a substrate for the ATPase. It can act as a reversible, competitive inhibitor of ATPase activity and can also induce an irreversible inhibition of ATPase activity. In parallel with the irreversible inhibition, covalent incorporation of [3H]o-ATP occurs. ATPase has about 1.05 mol of o-ATP bound per mol of ATPase when the enzyme is 50% inhibited. Most of the covalently bound o-ATP is associated with the alpha and beta subunits and is equally distributed between them. The incorporation of o-ATP into the ATPase is reduced, and the irreversible inhibition induced by o-ATP can be prevented totally by MgADP, MgATP, EDTA/ATP, or EDTA. The location, number, and the functional significance of the o-ATP binding sites are discussed. o-ATP can decompose to form an adenosine-containing compound and the tripolyphosphate anion in a beta-elimination reaction mechanism. The structures of the adenine-containing compound and its borohydride reduction product were determined. The adenine-containing elimination product inhibited the mitochondrial ATPase activity at a rate greater than that observed with o-ATP. The nature and mechanism of the inhibition of ATPase activity exerted by o-ATP and the elimination product were examined. The significance of the beta-elimination reaction to the use of periodate-oxidized nucleotides as affinity labels of nucleotide binding sites on other proteins is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215060     DOI: 10.1021/bi00260a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Cleavage of hexokinase II to two domains by trypsin without significant change in catalytic activity.

Authors:  H Okazaki; Y Takebayashi; M Ando; S Date; H Tokuda; S Ishibashi
Journal:  Mol Cell Biochem       Date:  1992-11-04       Impact factor: 3.396

2.  Oxidized ATP protection against anthrax lethal toxin.

Authors:  Mahtab Moayeri; Katherine E Wickliffe; Jason F Wiggins; Stephen H Leppla
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 3.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

4.  DNA duplexes with reactive dialdehyde groups as novel reagents for cross-linking to restriction- modification enzymes.

Authors:  M G Brevnov; O M Gritsenko; S N Mikhailov; E V Efimtseva; B S Ermolinsky; A Van Aerschot; P Herdewijn; A V Repyk; E S Gromova
Journal:  Nucleic Acids Res       Date:  1997-08-15       Impact factor: 16.971

5.  Covalent modification of Lys19 in the CTP binding site of cytidine 5'-monophosphate N-acetylneuraminic acid synthetase.

Authors:  M V Tullius; W F Vann; B W Gibson
Journal:  Protein Sci       Date:  1999-03       Impact factor: 6.725

6.  Using periodate-oxidized nucleotide as affinity label for the nucleotide site of proteins.

Authors:  C C Lin; G G Chang
Journal:  J Protein Chem       Date:  1993-10

7.  Structure-based site-directed mutagenesis of the UDP-MurNAc-pentapeptide-binding cavity of the FemX alanyl transferase from Weissella viridescens.

Authors:  Antoine P Maillard; Sabrina Biarrotte-Sorin; Régis Villet; Stéphane Mesnage; Ahmed Bouhss; Wladimir Sougakoff; Claudine Mayer; Michel Arthur
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

8.  Modification of human placental alkaline phosphatase by periodate-oxidized 1,N6-ethenoadenosine monophosphate.

Authors:  G G Chang; M S Shiao; K R Lee; J J Wu
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

9.  Proteins encoded by the bovine papillomavirus E1 open reading frame: expression in heterologous systems and in virally transformed cells.

Authors:  S Santucci; E J Androphy; C Bonne-Andréa; P Clertant
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

Review 10.  Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.

Authors:  D L Donnelly-Roberts; M F Jarvis
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.